37 related articles for article (PubMed ID: 211448)
21. Changes of rat cerebellar guanosine 3',5'-cyclic phosphate by dopaminergic mechanisms in vivo.
Burkard WP; Pieri L; Haefely W
Adv Biochem Psychopharmacol; 1976; 15():315-24. PubMed ID: 192051
[TBL] [Abstract][Full Text] [Related]
22. Regulation of cyclic GMP in cerebellum by a striatal dopaminergic mechanism.
Biggio G; Guidotti A
Nature; 1977 Jan; 265(5591):240-2. PubMed ID: 189208
[No Abstract] [Full Text] [Related]
23. Regulation of dopamine stimulation of striatal adenylate cyclase by an endogenous Ca++ -binding protein.
Gnegy ME; Uzunov P; Costa
Proc Natl Acad Sci U S A; 1976 Nov; 73(11):3887-90. PubMed ID: 186777
[TBL] [Abstract][Full Text] [Related]
24. Decrease of homovanillic, dihydroxyphenylacetic acid and cyclic-adenosine-3',5'-monophosphate content in the rat caudate nucleus induced by the acute administration of an aminoacid mixture lacking tyrosine and phenylalanine.
Biggio G; Porceddu ML; Gessa GL
J Neurochem; 1976 Jun; 26(6):1253-5. PubMed ID: 180254
[No Abstract] [Full Text] [Related]
25. Climbing fiver activation and 3', 5'-cyclic guanosine monophosphate (cGMP) content in cortex and deep nuclei of cerebellum.
Biggio G; Guidotti A
Brain Res; 1976 May; 107(2):365-73. PubMed ID: 178409
[TBL] [Abstract][Full Text] [Related]
26. Striatal lesions with kainic acid: neurochemical characteristics.
Schwarcz R; Coyle JT
Brain Res; 1977 May; 127(2):235-49. PubMed ID: 16686
[TBL] [Abstract][Full Text] [Related]
27. Pharmacologically induced changes in the 3':5'-cyclic guanosine monophosphate content of rat cerebellar cortex: difference between apomorphine, haloperidol and harmaline.
Biggio G; Costa E; Guidotti A
J Pharmacol Exp Ther; 1977 Jan; 200(1):207-15. PubMed ID: 13199
[TBL] [Abstract][Full Text] [Related]
28. Kainic acid-induced lesion of dopaminergic target cells in the striatum: consequences on the dynamics of cerebellar cGMP.
Biggio G; Corda MG; Casu M; Gessa GL
Naunyn Schmiedebergs Arch Pharmacol; 1978 Aug; 304(1):5-7. PubMed ID: 211448
[TBL] [Abstract][Full Text] [Related]
29. Striato-cerebellar pathway controlling cyclic GMP content in the cerebellum: role of dopamine, GABA and enkephalins.
Biggio G; Corda MG; Casu M; Gessa GL
Adv Biochem Psychopharmacol; 1978; 18():227-44. PubMed ID: 206110
[No Abstract] [Full Text] [Related]
30. Different mechanisms mediating the decrease of cerebellar cGMP elicited by haloperidol and diazepam.
Biggio G; Costa E; Guidotti A
Adv Biochem Psychopharmacol; 1976; 15():325-35. PubMed ID: 192052
[No Abstract] [Full Text] [Related]
31. Ergot alkaloids and cyclic nucleotides in the CNS.
Trabucchi M; Hofmann M; Montefusco O; Spano PF
Pharmacology; 1978; 16 Suppl 1():150-55. PubMed ID: 205889
[TBL] [Abstract][Full Text] [Related]
32. Cerebellar pathology in schizophrenia--cause or consequence?
Snider SR
Neurosci Biobehav Rev; 1982; 6(1):47-53. PubMed ID: 7041016
[TBL] [Abstract][Full Text] [Related]
33.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
